These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 19360342

  • 1. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.
    Seo S, Hatano E, Higashi T, Nakajima A, Nakamoto Y, Tada M, Tamaki N, Iwaisako K, Kitamura K, Ikai I, Uemoto S.
    Int J Oncol; 2009 May; 34(5):1303-12. PubMed ID: 19360342
    [Abstract] [Full Text] [Related]

  • 2. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
    Paudyal B, Paudyal P, Oriuchi N, Tsushima Y, Nakajima T, Endo K.
    Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathological presentation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcinoma and cholangiocellular carcinoma.
    Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Higuchi T, Miyakubo M, Ishikita T, Nakajima T, Endo K.
    Ann Nucl Med; 2008 Jan; 22(1):83-6. PubMed ID: 18250992
    [Abstract] [Full Text] [Related]

  • 4. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma.
    Seo S, Hatano E, Higashi T, Hara T, Tada M, Tamaki N, Iwaisako K, Ikai I, Uemoto S.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):427-33. PubMed ID: 17255262
    [Abstract] [Full Text] [Related]

  • 5. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
    Ong LC, Jin Y, Song IC, Yu S, Zhang K, Chow PK.
    Acta Radiol; 2008 Dec 15; 49(10):1145-53. PubMed ID: 18979289
    [Abstract] [Full Text] [Related]

  • 6. Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
    Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, Takei T, Tamaki N.
    J Nucl Med; 2005 Apr 15; 46(4):675-82. PubMed ID: 15809491
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
    Izuishi K, Yamamoto Y, Mori H, Kameyama R, Fujihara S, Masaki T, Suzuki Y.
    Oncol Rep; 2014 Feb 15; 31(2):701-6. PubMed ID: 24297035
    [Abstract] [Full Text] [Related]

  • 8. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
    Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J.
    J Nucl Med; 1995 Oct 15; 36(10):1811-7. PubMed ID: 7562048
    [Abstract] [Full Text] [Related]

  • 9. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
    Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M.
    Eur J Radiol; 2012 Jan 15; 81(1):146-51. PubMed ID: 20810231
    [Abstract] [Full Text] [Related]

  • 10. Biological correlates of FDG uptake in non-small cell lung cancer.
    de Geus-Oei LF, van Krieken JH, Aliredjo RP, Krabbe PF, Frielink C, Verhagen AF, Boerman OC, Oyen WJ.
    Lung Cancer; 2007 Jan 15; 55(1):79-87. PubMed ID: 17046099
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the role of hexokinase type II in cellular proliferation and apoptosis using human hepatocellular carcinoma cell lines.
    Ahn KJ, Hwang HS, Park JH, Bang SH, Kang WJ, Yun M, Lee JD.
    J Nucl Med; 2009 Sep 15; 50(9):1525-32. PubMed ID: 19690031
    [Abstract] [Full Text] [Related]

  • 12. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
    Lee JD, Yang WI, Park YN, Kim KS, Choi JS, Yun M, Ko D, Kim TS, Cho AE, Kim HM, Han KH, Im SS, Ahn YH, Choi CW, Park JH.
    J Nucl Med; 2005 Oct 15; 46(10):1753-9. PubMed ID: 16204727
    [Abstract] [Full Text] [Related]

  • 13. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
    Shim HK, Lee WW, Park SY, Kim H, Kim SE.
    Oncol Res; 2009 Oct 15; 17(7):331-7. PubMed ID: 19408578
    [Abstract] [Full Text] [Related]

  • 14. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M, Jeon JY, Neugent ML, Kim JW, Yun M.
    Clin Exp Metastasis; 2017 Apr 15; 34(3-4):251-260. PubMed ID: 28429188
    [Abstract] [Full Text] [Related]

  • 15. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.
    Yamamoto Y, Nishiyama Y, Kameyama R, Okano K, Kashiwagi H, Deguchi A, Kaji M, Ohkawa M.
    J Nucl Med; 2008 Aug 15; 49(8):1245-8. PubMed ID: 18632827
    [Abstract] [Full Text] [Related]

  • 16. Analysis of gene expression profiles of hepatocellular carcinomas with regard to 18F-fluorodeoxyglucose uptake pattern on positron emission tomography.
    Lee JD, Yun M, Lee JM, Choi Y, Choi YH, Kim JS, Kim SJ, Kim KS, Yang WI, Park YN, Han KH, Lee WJ, Yoo N, Lim SM, Park JH.
    Eur J Nucl Med Mol Imaging; 2004 Dec 15; 31(12):1621-30. PubMed ID: 15278306
    [Abstract] [Full Text] [Related]

  • 17. Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression.
    Alakus H, Batur M, Schmidt M, Drebber U, Baldus SE, Vallböhmer D, Prenzel KL, Metzger R, Bollschweiler E, Hölscher AH, Mönig SP.
    Nucl Med Commun; 2010 Jun 15; 31(6):532-8. PubMed ID: 20220543
    [Abstract] [Full Text] [Related]

  • 18. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
    Hamada K, Tomita Y, Qiu Y, Zhang B, Ueda T, Myoui A, Higuchi I, Yoshikawa H, Aozasa K, Hatazawa J.
    Ann Nucl Med; 2008 Oct 15; 22(8):699-705. PubMed ID: 18982473
    [Abstract] [Full Text] [Related]

  • 19. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors.
    Song JY, Lee YN, Kim YS, Kim SG, Jin SJ, Park JM, Choi GS, Chung JC, Lee MH, Cho YH, Choi MH, Kim DC, Choi HJ, Moon JH, Lee SH, Jeong SW, Jang JY, Kim HS, Kim BS.
    Nucl Med Commun; 2015 Apr 15; 36(4):319-27. PubMed ID: 25564069
    [Abstract] [Full Text] [Related]

  • 20. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
    Park SG, Lee JH, Lee WA, Han KM.
    Nucl Med Biol; 2012 Nov 15; 39(8):1167-72. PubMed ID: 22901702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.